The boom experienced by the weight loss drug market comes as little surprise when considering that almost a third of the ...

Nationally, employers could see total health insurance costs rise 5.8% on average in 2025. KC won't be spared costlier ...

Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for ...

Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).

Doctors have been urged to look out for 'signs of misuse' among patients using weight loss drugs. | ITV National News ...

The diabetes and weight loss drug Ozempic could lower the risk of Alzheimer’s disease among people with type 2 diabetes, ...

According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the ...

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia? Scientists have exciting news about semaglutide.

As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial headwinds to pay for prescription drugs for weight loss. Semaglutide, the generic ...

Quebec's health insurance board currently doesn't cover Ozempic and similar weight-loss medication unless they are prescribed for patients who are diagnosed with diabetes.

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...